“Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism.”, Thromb Res, vol. 188, pp. 106-114, 2020.
, “Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open Label Phase 1 Multiple Ascending Dose and Food Effect Study.”, Antimicrob Agents Chemother, 2020.
, “Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine.”, Vaccines (Basel), vol. 8, no. 1, 2020.
, “Population Pharmacokinetics of Metoclopramide in Infants, Children, and Adolescents.”, Clin Transl Sci, 2020.
, “Population pharmacokinetics of olanzapine in children.”, Br J Clin Pharmacol, 2020.
, “A population-based approach to reporting system-level performance measures for rheumatoid arthritis care.”, Arthritis Care Res (Hoboken), 2020.
, “Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola.”, Emerg Infect Dis, vol. 26, no. 3, pp. 541-548, 2020.
, “Prenatal Practice Staff Perceptions of Three Substance Use Screening Tools for Pregnant Women.”, J Addict Med, vol. 14, no. 2, pp. 139-144, 2020.
, , “Prevalence of obesity among U.S. population with substance dependence.”, Drug Alcohol Depend, vol. 217, p. 108293, 2020.
, “A Prospective Cohort Study to Evaluate the Impact of Diet, Exercise, and Lifestyle on Fertility (IDEAL): Design and Baseline Characteristics.”, Am J Epidemiol, 2020.
, “Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine.”, Vaccines (Basel), vol. 8, no. 3, 2020.
, “Partnering, Not Enduring: Citizen Science and Research Participation.”, Am J Bioeth, vol. 19, no. 9, pp. 44-45, 2019.
, , “Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study.”, Antimicrob Agents Chemother, vol. 63, no. 4, 2019.
, “A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA-AF) in healthy adults from a non-endemic area.”, Vaccine, vol. 37, no. 43, pp. 6500-6509, 2019.
, “A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III.”, Clin Infect Dis, vol. 68, no. 12, pp. 2079-2086, 2019.
, “Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers.”, Antimicrob Agents Chemother, vol. 63, no. 9, 2019.
, “Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide.”, J Clin Oncol, vol. 37, no. 5, pp. 367-374, 2019.
, “Population Pharmacokinetics of Doxycycline in Children.”, Antimicrob Agents Chemother, 2019.
, “Population Pharmacokinetics of Milrinone in Infants, Children, and Adolescents.”, J Clin Pharmacol, vol. 59, no. 12, pp. 1606-1619, 2019.
, “Prenatal Substance Use and Perceptions of Parent and Partner Use Using the 4P's Plus Screener.”, Matern Child Health J, vol. 23, no. 2, pp. 250-257, 2019.
, “Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21.”, Ophthalmology, vol. 126, no. 12, pp. 1659-1666, 2019.
, “Participant Retention in a Randomized Clinical Trial in an Outbreak Setting: Lessons From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).”, J Infect Dis, vol. 217, no. suppl_1, pp. S65-S74, 2018.
, “A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei.”, Vaccine, vol. 36, no. 32 Pt B, pp. 4880-4889, 2018.
,